Increasing access to HIV prevention for young Black and Latino men who have sex with men
RFA-PS-21-003: PrEP Choice: Increasing the Use of HIV Pre-exposure Prophylaxis in an Era of Choices
This study is looking at how to make it easier for young Black and Latino men who have sex with men to access and stick with PrEP, a medication that helps prevent HIV, by finding out what challenges they face and improving support and information about it.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10844338 on NIH RePORTER |
What this research studies
This research focuses on improving the use of pre-exposure prophylaxis (PrEP) among young Black and Latino men who have sex with men (MSM), who are at the highest risk for HIV infection. The study aims to identify and address barriers that prevent these populations from accessing and adhering to PrEP, including both provider-level and patient-level challenges. By exploring different PrEP options and enhancing counseling and screening practices, the research seeks to ensure that effective HIV prevention tools are culturally relevant and accessible. The ultimate goal is to increase PrEP uptake and reduce new HIV infections in these high-risk groups.
Who could benefit from this research
Good fit: Ideal candidates for this research are young Black and Latino men who have sex with men and are at high risk for HIV infection.
Not a fit: Patients who are not at risk for HIV or who do not identify as men who have sex with men may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase the number of young Black and Latino MSM using PrEP, thereby reducing HIV transmission rates in these communities.
How similar studies have performed: Previous research has shown success in increasing PrEP uptake among high-risk populations through targeted interventions, indicating that this approach has potential.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Schnall, Rebecca — Columbia University Health Sciences
- Study coordinator: Schnall, Rebecca
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.